DexCom Inc., a San Diego-based medical device company, reported total revenue grew to $58.8 million for the second quarter of 2014, up 64 percent from the same quarter last year. The company also reported a net loss of $6 million, down from a net loss of $10.1 million in the 2013 second quarter.
DexCom (NASDAQ: DXCM) is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and healthcare providers in hospitals.
For more on Dexcom’s results, click here.